Avid Bioservices (NASDAQ:CDMO) rose 1.6% as a holder said that it's opposed the planned $12.50 a share sale to GHO Capital ...
Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital ...
Avid Bioservices shares were up 12% at $12.25 after getting a buyout offer from GHO Capital Partners and Ampersand Capital Partners. Under the terms of the buyout, Avid will be acquired by funds ...
CDMO Avid Bioservices will be taken private by GHO Capital Partners and Ampersand Capital Partners in a deal worth $1.1 ...
Browse insider trades on all stocks. Form 4 Filing Late Tuesday Showed Avid Biosciences Director Carleone Bought 44.445K Shares At $2.25 As Part Of a Recent Offering ...
Avid Bioservices (NASDAQ:CDMO) has agreed to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners through a cash deal that values the company at around $1.1B. Avid ...